Igy Immunologix India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
- Revenue Growth -19.50%
- Profit Growth -43.65%
- Ebitda -178.29%
- Net Worth 25.67%
- Total Assets 8.96%
About Igy Immunologix India
Igy Immunologix India Private Limited (IIIPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 February 2014 and has a history of 11 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Mona Gupta and Adinarayana Yerrapureddy serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74900TG2014PTC093097
- Company No.
093097
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Life Sciences
Igy Immunologix India Private Limited
Explore comprehensive data for Igy Immunologix India Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Igy Immunologix India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mona Gupta  | Director | 21-Feb-2014 | Current |
| Adinarayana Yerrapureddy | Director | 21-Feb-2014 | Current |
Financial Performance of Igy Immunologix India.
Igy Immunologix India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 19.5% decrease. The company also saw a substantial fall in profitability, with a 43.65% decrease in profit. The company's net worth Soared by an impressive increase of 25.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Igy Immunologix India?
In 2019, Igy Immunologix India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zealous Health Private LimitedMona Gupta and Adinarayana Yerrapureddy are mutual person
Excel Immunologix India Private LimitedMona Gupta and Adinarayana Yerrapureddy are mutual person
- Imkuraq Animal Health Private Limited
Mona Gupta and Adinarayana Yerrapureddy are mutual person
- Pomona Agri Science Private Limited
Adinarayana Yerrapureddy is a mutual person
Charges (Loans)
Open Charges
₹2.50 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jul 2016 | Bank Of India | ₹2.50 M | Open |
How Many Employees Work at Igy Immunologix India?
Unlock and access historical data on people associated with Igy Immunologix India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Igy Immunologix India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Igy Immunologix India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Igy Immunologix India
Recent activity within the organization
- Annual General Meeting
Igy Immunologix India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Igy Immunologix India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Charges
A charge with Bank Of India amounted to Rs. 2.50 M with Charge ID 100056052 was registered on 13 Jul 2016.
- Director Appointment
Mona Gupta was appointed as a Director was appointed as a Director on 21 Feb 2014 & has been associated with this company since 11 years 2 months .
- Director Appointment
Adinarayana Reddy Yerrapureddy was appointed as a Director was appointed as a Director on 21 Feb 2014 & has been associated with this company since 11 years 2 months .
- Company Incorporation
Igy Immunologix India Private Limited was registered on 21 Feb 2014 with Roc Hyderabad & aged 11 years 2 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Igy Immunologix India Private Limited?
Igy Immunologix India Private Limited was incorporated on 21 Feb 2014.
What is authorized share capital and paid-up capital of Igy Immunologix India Private Limited?
The authorized share capital of Igy Immunologix India Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Igy Immunologix India Private Limited?
Currently 2 directors are associated with Igy Immunologix India Private Limited.
- Mona Gupta
- Adinarayana Reddy Yerrapureddy
What is the registered address of Igy Immunologix India Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Igy Immunologix India Private Limited is 2903 Lh17 Lanco Hills Manikonda, India, Hyderabad, Telangana, 500089.
What is the corporate identification number (CIN) and company number of Igy Immunologix India Private Limited?
The corporate identification number (CIN) of Igy Immunologix India Private Limited is U74900TG2014PTC093097 and the company number is 093097 as per Ministry of Corporate Affairs (MCA).
What is the official website of Igy Immunologix India Private Limited?
The Official website of Igy Immunologix India Private Limited is https://www.igylx.com
What has been the recent revenue trend for Igy Immunologix India Private Limited?
According to the financial reports for the fiscal year 2020, the revenue trend for Igy Immunologix India Private Limited has fallen by -19.50%.
What change has been observed in the net worth of Igy Immunologix India Private Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Igy Immunologix India Private Limited has experienced an upsurge of 25.67%.
What are the total open charges for Igy Immunologix India Private Limited?
As per the financial statements for fiscal Year 2020, The total open charges for Igy Immunologix India Private Limited amount to ₹ 2.50 M.
When was the last Balance Sheet of Igy Immunologix India Private Limited filed with the ROC?
The most recent Balance Sheet for Igy Immunologix India Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records